Bridging the ‘Open Water’ in the US-South Korea Military Alliance

2003 ◽  
Vol 15 (2) ◽  
pp. 153-176
Author(s):  
Gregory F. Treverton ◽  
Eric Larson ◽  
Spencer H. Kim
2021 ◽  
Vol 24 (2) ◽  
pp. 97-117
Author(s):  
Sojeong Lee ◽  
Brandon Prins ◽  
Krista E. Wiegand

Since the end of World War II, the US military has continuously deployed troops to South Korea. The alliance works as an asymmetrical alliance, where the US is a patron and South Korea is a protégé. While it is argued that this deployment has significant political, economic, and military effects on South Korea and the region, few studies have examined how the presence of US forces there enhances US military and economic power as well as national security interests. In this paper, we examine the costs and benefits of the US–South Korea alliance, specifically focusing on US troop deployment on the Korean Peninsula. In particular, we argue that the US military alliance with South Korea has significant benefits to both partners, but particularly for the sake of US national security interests. In this sense, the protégé state provides significant benefits to the patron state. We discuss the strategic importance of South Korea in US foreign policy in the region and emphasize the benefits of the US–South Korea alliance at the various levels.


Author(s):  
Andrew Yeo

Chapter 4 describes the rising phenomena of East Asian regionalism in the wake of the Asian financial crisis and demonstrates how debates between inclusive and exclusive variations of Asian regionalism played out in the development of the regional architecture. The chapter traces the establishment of the ASEAN Plus Three, the East Asia Summit, and the Six-Party Talks. Taken together, these three institutions signified greater political will behind regional multilateralism but also revealed the contentious nature of institution building. The discussion of multilateral developments is juxtaposed to an analysis of the US–South Korea and US-Thailand alliances, and their resilience in an era of greater multilateralism and expanding regionalism.


Significance Year-on-year GDP growth was little changed at 2.7% in the first quarter after easing to 2.8% in 2015 and 2016 from an average of 3.7% in the five years to 2014. In 2016 consumer spending grew by less than 2.5%, machinery investment did not grow at all and net export volumes subtracted from growth. Impacts The US administration may threaten to pull out of the US-South Korea free-trade deal unless terms are renegotiated. Samsung in the first quarter of 2017 reported its best profits since 2013, but it will face an increasingly competitive market. Talk of reunification with North Korea as a solution to demographic pressures is fanciful.


BMJ ◽  
2021 ◽  
pp. n1038
Author(s):  
Albert Prats-Uribe ◽  
Anthony G Sena ◽  
Lana Yin Hui Lai ◽  
Waheed-Ul-Rahman Ahmed ◽  
Heba Alghoul ◽  
...  

Abstract Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-19 across three continents. Design Multinational network cohort study. Setting Hospital electronic health records from the United States, Spain, and China, and nationwide claims data from South Korea. Participants 303 264 patients admitted to hospital with covid-19 from January 2020 to December 2020. Main outcome measures Prescriptions or dispensations of any drug on or 30 days after the date of hospital admission for covid-19. Results Of the 303 264 patients included, 290 131 were from the US, 7599 from South Korea, 5230 from Spain, and 304 from China. 3455 drugs were identified. Common repurposed drugs were hydroxychloroquine (used in from <5 (<2%) patients in China to 2165 (85.1%) in Spain), azithromycin (from 15 (4.9%) in China to 1473 (57.9%) in Spain), combined lopinavir and ritonavir (from 156 (<2%) in the VA-OMOP US to 2,652 (34.9%) in South Korea and 1285 (50.5%) in Spain), and umifenovir (0% in the US, South Korea, and Spain and 238 (78.3%) in China). Use of adjunctive drugs varied greatly, with the five most used treatments being enoxaparin, fluoroquinolones, ceftriaxone, vitamin D, and corticosteroids. Hydroxychloroquine use increased rapidly from March to April 2020 but declined steeply in May to June and remained low for the rest of the year. The use of dexamethasone and corticosteroids increased steadily during 2020. Conclusions Multiple drugs were used in the first few months of the covid-19 pandemic, with substantial geographical and temporal variation. Hydroxychloroquine, azithromycin, lopinavir-ritonavir, and umifenovir (in China only) were the most prescribed repurposed drugs. Antithrombotics, antibiotics, H2 receptor antagonists, and corticosteroids were often used as adjunctive treatments. Research is needed on the comparative risk and benefit of these treatments in the management of covid-19.


Sign in / Sign up

Export Citation Format

Share Document